To access this element change to forms mode OFF
Grant Award View - GA65905
Mutation-Centric Therapy for JAK2 vs CALR Mutated Myelofibrosis
GA ID:
GA65905
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$661,237.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Mutation-Centric Therapy for JAK2 vs CALR Mutated Myelofibrosis
Purpose:
Myelofibrosis is a chronic bone marrow disorder of elderly patients characterised by fatigue and bone pain, disappointingly, but current treatment designed to treat myelofibrosis have not proven to eradicate the disease-causing cells and have unexpected side effects. By carefully studying the signals inside patient cells, we have uncovered two therapeutic strategies that have great potential to reduce side effects and improve response rates according to the molecular changes in each patient.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1182564
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of South Australia
Recipient ABN:
37 191 313 308
Grant Recipient Location
Suburb:
Mawson Lake
Town/City:
Mawson Lake
Postcode:
5095
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
SA
Postcode:
Country:
AUSTRALIA